MedTrace Logo

Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia?

NCT01278459 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2015-06-01

No results posted yet for this study

Summary

The purpose of the study is to test the hypothesis that a short course of atorvastatin can improve vascular function in women with a history of preeclampsia, compared to placebo.

Conditions

  • Pre-Eclampsia

Interventions

DRUG

Atorvastatin

4 week treatment, 20mg/day taken orally in tablet form

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Paul Leeson, PhD MRCP FESC · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01278459 on ClinicalTrials.gov